Skip links

Creating breakthrough solutions for the medical device industry…

Revolutionary, advanced, and very much in-demand; Bioxis specializes in the discovery, development, production, and commercialization of innovative regenerative medical products. Through groundbreaking solutions, we develop popular products that help doctors improve the quality of care of their patients in the dermatology and medical aesthetic fields. We’re a young company that’s one of the industry’s fastest growing businesses; quickly developing outstanding new ideas and innovations that are transforming the medical aesthetics.

CYTOSIAL

Monophasic Hyaluronic Acid to Reduce the Signs of Aging With a Double-Level Molecular Organization that Provides Elevated Rheological Performance, Long-Lasting Effect and Safety.

CYTOSIAL PRODUCT RANGE

Is indicated for
The filling of moderate cutaneous depressions
as
perioral or commissural area

HA concentration : 25 mg/mL
Volume : 1.1 ml
Needle size : 271/2G or 30G
Injection : Mid dermis
Ejection force : 10 – 25 N
BDDE rate : 1.15%
BDDE residual rate : idem BDDE residual

Correct deep lines:
Deep nasolabial fold
Deep marionette fold

HA concentration : 25 mg/mL
Volume : 1.1 ml
Needle size : 27.5G
Injection : Deep dermis
Ejection force : 10 – 25 N
BDDE rate : 1.50%
BDDE residual rate : ≤ ppm

Restore facial volume:
cheeks and cheekbones
chin
facial volume loss

HA concentration : 25 mg/mL
Volume : 1.1 ml
Needle size : 27.5G
Injection : Deep dermis & subcutaneous
Ejection force : 10 – 25 N
BDDE rate : 2.15%
BDDE residual rate : ≤ 2 ppm

For more information, please visit

http://bioxis.com/